Zobrazeno 1 - 10
of 398
pro vyhledávání: '"Alexander Reinthaller"'
Autor:
Christine Bekos, Dietmar Pils, Sabine Dekan, Gerda Hofstetter, Peter Horak, Alexander Reinthaller, Stephan Polterauer, Richard Schwameis, Stefanie Aust
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract The therapeutic potential of immune checkpoint inhibitors is currently being investigated in epithelial ovarian cancer (EOC), but immunological effects of the programmed cell death protein 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) ax
Externí odkaz:
https://doaj.org/article/f6b4df31ae53472281d4202e85652f46
Autor:
Veronika Seebacher, Stephan Polterauer, Alexander Reinthaller, Heinz Koelbl, Regina Achleitner, Astrid Berger, Nicole Concin
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background AB0 blood groups and Rhesus factor expression have been associated with carcinogenesis, response to treatment and tumor progression in several malignancies. The aim of the present study was to test the hypothesis that AB0 blood gr
Externí odkaz:
https://doaj.org/article/23a1e5f773d4482faa4697b9e7d2523f
Autor:
Stephan Polterauer, Olaf Reich, Andreas Widschwendter, Laudia Hadjari, Gerhard Bogner, Alexander Reinthaller, Elmar Joura, Gerda Trutnovsky, Alexandra Ciresa-Koenig, Julia Ganhoer-Schimboeck, Ina Boehm, Regina Berger, Eva Langthaler, Stephan W. Aberle, Georg Heinze, Andreas Gleiss, Christoph Grimm
Publikováno v:
Gynecologic Oncology. 165:23-29
In a previous phase II trial, we showed that topical imiquimod (IMQ) therapy is an efficacious treatment for high-grade squamous intraepithelial lesion (HSIL). Aim of the present study was to investigate the non-inferiority of a 16-week topical, self
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3dd2185e619fd3441364f4d1efa3ddd
https://doi.org/10.1016/j.ygyno.2022.01.033
https://doi.org/10.1016/j.ygyno.2022.01.033
Autor:
Christine Bekos, Christoph Grimm, Lisa Gensthaler, Thomas Bartl, Alexander Reinthaller, Richard Schwameis, Stephan Polterauer
Publikováno v:
Geburtshilfe und Frauenheilkunde
Introduction The Controlling Nutritional (CONUT) Status score is an established predictor of impaired prognosis in patients with solid tumors. The aim of this study was to investigate the prognostic value of the CONUT score for overall survival and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a8b93a263531bf8de821321f48340c9
https://doi.org/10.1055/a-1608-1309
https://doi.org/10.1055/a-1608-1309
Autor:
Veronika Seebacher, Stefanie Aust, David D'Andrea, Christoph Grimm, Elisabeth Reiser, Denise Tiringer, Hannah Von Mersi, Stephan Polterauer, Alexander Reinthaller, Samir Helmy-Bader
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182383 (2017)
To develop a tool for individualized risk estimation of presence of cancer in women with adnexal masses, and to assess the added value of plasma fibrinogen.We performed a retrospective analysis of a prospectively maintained database of 906 patients w
Externí odkaz:
https://doaj.org/article/106f3cad290544448274909a5a75fb48
Autor:
Veronika Seebacher, Alexander Reinthaller, Heinz Koelbl, Nicole Concin, Regina Nehoda, Stephan Polterauer
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169272 (2017)
OBJECTIVE:The aim of the present study was to investigate the prognostic role of the duration of adjuvant chemotherapy in patients with epithelial ovarian, fallopian tube and primary peritoneal cancer (EOC). MATERIALS AND METHODS:Within the present s
Externí odkaz:
https://doaj.org/article/b24103074063468b905b6d5ae8c37eac
Autor:
Christina T. Grech, Dietmar Pils, Stefanie Aust, Christoph Grimm, Stephan Polterauer, Alexander Reinthaller, Leonhard Müllauer, Theresa Reischer, Christine Bekos
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 9; Pages: 1467
PARP inhibitors (PARPi) have increased treatment options in ovarian cancer, particularly in patients with BRCA1/2 mutations, although there are still marked differences in the duration of patients’ response to this targeted therapy. BRCA testing is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83e302c0ecaff95bf7ae4fef588574fe
Autor:
Sabine Dekan, Christine Bekos, Stephan Polterauer, Peter Horak, Richard Schwameis, Stefanie Aust, Dietmar Pils, Alexander Reinthaller, Gerda Hofstetter
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
The therapeutic potential of immune checkpoint inhibitors is currently being investigated in epithelial ovarian cancer (EOC), but immunological effects of the programmed cell death protein 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) axis in EOC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73ab7142e28c5a0fcd4c83d965310b53
https://doaj.org/article/f6b4df31ae53472281d4202e85652f46
https://doaj.org/article/f6b4df31ae53472281d4202e85652f46
Autor:
Sabine Clauss, C Ebner, Elisabeth Thell, Marina Schinnerl, Alexander Reinthaller, Birgit Hofstätter, G Bogner, Katharina Hrauda, Mirijam Hall, Andrea Schilcher, Christian F. Singer, Thomas Aigmüller, I Tsibulak, Johanna Hell-Teutsch, Daniela Gangl, K Knoll, E Reiser, Doris Hittler, Gottfried Gamperl, Barbara Puschacher, Cornelia Weirather, Johanna Pozniak, Verena Sigl, Edgar Petru, Christian Marth, K Leitner, Sebastian Alicke, Tatjana Weiss, Szabolcs Bozsa
Publikováno v:
International Journal of Gynecologic Cancer
International Journal of Gynecological Cancer
International Journal of Gynecological Cancer
BackgroundOn March 16, 2020, the federal government of Austria declared a nationwide lockdown due to the COVID-19 pandemic. Since the lockdown, screening examinations and routine checkups have been restricted to prevent the spread of the virus and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6236843389ec8e5a1507fec14a52cc91
https://doi.org/10.1136/ijgc-2020-001975
https://doi.org/10.1136/ijgc-2020-001975
Autor:
Marijana Ninkovic, Bela Teleky, Tobias Zott, Bernhard Dauser, Ioannis Lazaridis, Eloy Espin Basany, Marlene Kranawetter, Cherry Koh, Ingrid Tapiolas, Stefan Riss, Friedrich Herbst, Anton Stift, Alexander Reinthaller, Felix Harpain, Marc-Olivier Guenin, Irmgard E. Kronberger, Christoph Grimm
Publikováno v:
International Journal of Surgery. 78:97-102
Background Low anterior resection syndrome (LARS) is a common functional disorder after low anterior resection impacting the quality of life. Data on LARS derives nearly exclusively from rectal cancer studies. Therefore, the study was designed to ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::607c1dde26d4af348086fb3da3175146
https://doi.org/10.1016/j.ijsu.2020.04.019
https://doi.org/10.1016/j.ijsu.2020.04.019